First Comparison of Amulet and Watchman FLX LAA Closure Devices

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Diagnostic and Interventional Cardiology

Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System

Abbott Vascular

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Structural Heart Occluders

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

TCT DAIC

Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System

Diagnostic and Interventional Cardiology